Filters close
Newswise: American Thoracic Society Announces Platinum Status from GuideStar
Released: 18-Sep-2024 10:05 AM EDT
American Thoracic Society Announces Platinum Status from GuideStar
American Thoracic Society (ATS)

We are excited to announce that the American Thoracic Society has achieved GuideStar Platinum Status. As a 501c3 non-profit organization, the ATS leverages donations to further its mission to accelerate global innovation to advance respiratory health through multidisciplinary collaboration, education and advocacy.

Newswise: The hidden metabolic landscape: unraveling the genetic underpinnings of Artemisia annua
Released: 18-Sep-2024 10:05 AM EDT
The hidden metabolic landscape: unraveling the genetic underpinnings of Artemisia annua
Chinese Academy of Sciences

A recent study study has revealed critical insights into the metabolic landscape of Artemisia annua, a plant essential for artemisinin production, the cornerstone of malaria treatment. Researchers investigated a mutant strain with developmental defects in glandular secretory trichomes (GSTs), which are vital for artemisinin synthesis. The study uncovered severe disruptions in the plant’s metabolic pathways, notably hindering artemisinin and other key secondary metabolites. These findings could pave the way for enhanced strategies to boost artemisinin yield, potentially transforming malaria treatment.

   
Released: 18-Sep-2024 10:05 AM EDT
Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit
Zymo Research Corp

Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology.

   
Newswise: 1920_fall-risk-older-couple-sas-cedars-sinai.jpg?10000
Released: 18-Sep-2024 9:05 AM EDT
Cedars-Sinai Helps Older Adults Overcome Fear of Falling
Cedars-Sinai

The most common trauma injuries at Cedars-Sinai are the result of age-related falls. That’s why Gregory Jones, RN, injury prevention and outreach coordinator for the hospital’s Trauma Program, is on a mission to help older adults avoid risk factors and prevent falls.

Released: 18-Sep-2024 9:05 AM EDT
UChicago Medicine Patient First in the World to Receive Ulcerative Colitis Drug Since FDA Approval
University of Chicago Medical Center

A University of Chicago Medicine patient became the first in the world to receive the drug guselkumab (Tremfya) since its Sept. 11 approval by the FDA for treating moderate to severe ulcerative colitis.

Newswise: Candise (Candy) Dolan, CNCT, R.NCS.T., R.EEGT., Receives AANEM's 2024 Outstanding Service Award
Released: 18-Sep-2024 9:05 AM EDT
Candise (Candy) Dolan, CNCT, R.NCS.T., R.EEGT., Receives AANEM's 2024 Outstanding Service Award
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Ms. Candy Dolan as the 2024 Outstanding Service Award recipient for her dedicated service to her patients, technologists, residents and fellows, and AANEM.

   
Newswise: Penny for Your Thoughts? Master Copper Regulator Discovery May Offer Alzheimer’s Clues
Released: 18-Sep-2024 8:30 AM EDT
Penny for Your Thoughts? Master Copper Regulator Discovery May Offer Alzheimer’s Clues
Florida Atlantic University

A groundbreaking study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers have linked the worm gene swip-10 to copper regulation – a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications and opens new avenues for advancing brain disease treatments.

Released: 18-Sep-2024 8:25 AM EDT
ASTRO Awards Early Career Radiation Oncology Scientists with Research Grants and Fellowships
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) today announced the recipients of its 2024 research grants and fellowships, including awards co-sponsored by the American Cancer Society (ACS), the LUNGevity Foundation, the Melanoma Research Alliance (MRA), the American Association of Physicists in Medicine (AAPM), the RTOG Foundation/NRG Oncology and AstraZeneca.

Newswise: Polluted Air, Disturbed Hearts: Study Ties Air Quality to Cardiac Health
Released: 18-Sep-2024 8:05 AM EDT
Polluted Air, Disturbed Hearts: Study Ties Air Quality to Cardiac Health
Chinese Academy of Sciences

A recent study has uncovered a significant link between chronic exposure to air pollution and an increased risk of various arrhythmias, representing a pivotal advance in environmental health research.

   
Newswise: The Hidden Health Risks of Styrene and Ethylbenzene Exposure
Released: 18-Sep-2024 7:05 AM EDT
The Hidden Health Risks of Styrene and Ethylbenzene Exposure
Chinese Academy of Sciences

A recent study conducted by the Department of Occupational and Environmental Health at Tongji Medical College, Huazhong University of Science and Technology, reveals a strong link between exposure to styrene and ethylbenzene, common air pollutants, and an increased risk of developing type 2 diabetes mellitus (T2DM).

   
Newswise: Keck Hospital of USC Named a 2024 Top Performer by Vizient, Inc.
18-Sep-2024 7:05 AM EDT
Keck Hospital of USC Named a 2024 Top Performer by Vizient, Inc.
Keck Medicine of USC

Keck Hospital of USC has been named a top performer in the 2024 Bernard A. Birnbaum, MD, Quality Leadership award by Vizient, Inc., a leading health care performance improvement company.

Newswise:Video Embedded endurance-exercise-without-weight-loss-may-reduce-body-fat
VIDEO
Released: 18-Sep-2024 7:00 AM EDT
Endurance Exercise without Weight Loss May Reduce Body Fat
American Physiological Society (APS)

Participating in a high volume of exercise over a short period of time, such as cycling hundreds of miles in a few days, could reduce body fat levels without weight loss. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism and has been chosen as an APSselect article for September.

Released: 18-Sep-2024 6:05 AM EDT
Mude O Seu Estilo De Vida Para Reduzir Seu Risco De Desenvolver CâNcer: Especialista Da Mayo Clinic Explica Como
Mayo Clinic

Cerca de um terço da metade dos casos de câncer são evitáveis, de acordo com a Organização Mundial Da Saúde. O Dr. Jon Ebbert, diretor médico do Centro de Dependência de Nicotina da Mayo Clinic, diz que nunca é tarde demais para fazer mudanças no estilo de vida que possam diminuir o seu risco de desenvolver câncer.

Released: 18-Sep-2024 6:00 AM EDT
Cambie su estilo de vida para reducir su riesgo de desarrollar cáncer: un experto de Mayo Clinic explica cómo
Mayo Clinic

Aproximadamente un tercio de la mitad de los casos de cáncer se pueden prevenir, según la Organización Mundial de la Salud. El Dr. Jon Ebbert, director médico del Centro de Adicción a la Nicotina de Mayo Clinic, dice que nunca es demasiado tarde para hacer cambios en el estilo de vida que puedan disminuir su riesgo de desarrollar cáncer.

Released: 18-Sep-2024 3:05 AM EDT
تغيير نمط الحياة يقلل خطر الإصابة بالسرطان: يشرح خبير مايو كلينك الكيفية
Mayo Clinic

روتشستر، ولاية مينيسوتا — يمكن الوقاية من حوالى ثلث إلى نصف حالات السرطان، وذلك وفقًا لتصريح منظمة الصحة العالمية. يقول جون إيبرت، دكتور في الطب، المدير الطبي لمركز علاج إدمان النيكوتين، أنه لم يفت الأوان أبدًا لإجراء تغييرات في نمط الحياة والتي من شأنها تقليل خطر الإصابة بمرض السرطان.

Released: 17-Sep-2024 8:05 PM EDT
Studies Deepen Understanding of LGBTQ Health Disparities
Harvard Medical School

Three new studies pinpoint challenges and opportunities for closing health disparities for LGBTQ+ people, showing how the convergence of political and social environments, structural inequities, and implicit and explicit bias within the medical system erode LGBTQ+ well-being.

17-Sep-2024 1:30 PM EDT
Novel Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia
University of Texas MD Anderson Cancer Center

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib.



close
0.27148